Summary:The fiscal year 2025 (FY25) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY25 PRMRP topic areas and FY25 PRMRP strategic goals.Distinctive Features:• Clinical trials are required.• Animal studies are NOT allowed under this award mechanism. All preclinical work must be completed...